|
Market Closed -
Nasdaq
04:00:00 19/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 784.85 USD | -0.58% |
|
+0.43% | +1.68% |
| Market Cap | 78.83B 68.74B 64.91B 58.94B 110B 7,564B 111B 777B 300B 3,846B 296B 290B 12,374B | P/E 2026 * |
18.3x | P/E 2027 * | 15.7x |
|---|---|---|---|---|---|
| Enterprise Value | 71.66B 62.49B 59B 53.58B 100B 6,876B 101B 707B 273B 3,496B 269B 263B 11,248B | EV / Sales 2026 * |
4.23x | EV / Sales 2027 * | 3.72x |
| Free-Float |
71.06% | Yield 2026 * |
0.49% | Yield 2027 * | 0.56% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Xetra
| RGO | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.58% | ||
| 1 week | +0.43% | ||
| Current month | -1.78% | ||
| 1 month | -3.13% | ||
| 3 months | +28.68% | ||
| 6 months | +5.47% | ||
| Current year | +1.68% |
| 1 week | 769.57 |  | 798.84 |
| 1 month | 769.57 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.58% | +0.43% | +31.09% | -4.81% | 78.83B | |
| -1.11% | +3.59% | -12.67% | -34.40% | 60.48B | |
| -2.55% | +6.99% | +505.27% | +47.92% | 63.11B | |
| +0.14% | -1.76% | -10.86% | +24.38% | 46.75B | |
| -0.24% | +3.17% | +2.51% | +147.15% | 45.66B | |
| -1.62% | -0.76% | +49.85% | -14.92% | 32.37B | |
| -1.81% | +3.16% | +45.71% | +110.57% | 25.87B | |
| +0.47% | +2.38% | +0.10% | +146.43% | 21.33B | |
| +0.27% | +1.87% | +63.02% | +99.38% | 15.8B | |
| -1.04% | -8.05% | +24.90% | +133.39% | 13.16B | |
| Average | -0.80% | +2.34% | +69.89% | +65.51% | 40.33B | |
| Weighted average by Cap. | -0.92% | +3.57% | +92.47% | +42.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.93B 14.76B 13.94B 12.66B 23.71B 1,624B 23.81B 167B 64.42B 826B 63.58B 62.17B 2,657B | 18.48B 16.12B 15.22B 13.82B 25.89B 1,774B 26B 182B 70.35B 902B 69.43B 67.89B 2,901B |
| Net income | 4.77B 4.16B 3.93B 3.57B 6.69B 458B 6.71B 47.08B 18.17B 233B 17.93B 17.53B 749B | 5.45B 4.75B 4.48B 4.07B 7.63B 523B 7.66B 53.71B 20.73B 266B 20.46B 20B 855B |
| Net Debt | -7.17B -6.25B -5.91B -5.36B -10.05B -688B -10.09B -70.74B -27.3B -350B -26.94B -26.34B -1,126B | -10.05B -8.77B -8.28B -7.52B -14.09B -965B -14.14B -99.17B -38.27B -491B -37.77B -36.93B -1,578B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/09/26 | US$784.85 | -0.58% | 2,472,602 |
| 17/09/26 | US$789.45 | +1.92% | 702,816 |
| 16/09/26 | US$774.61 | +0.06% | 382,945 |
| 15/09/26 | US$774.11 | -2.47% | 540,837 |
| 14/09/26 | US$793.74 | +1.57% | 591,295 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
